Nancy Rothwell

Nancy Rothwell is the President and Vice-Chancellor of The University of Manchester and holds the academic rank of Professor of Physiology. She obtained a BSc, PhD, and DSc from the University of London. Her research focuses on inflammation’s role in brain diseases, particularly stroke and brain hemorrhage, emphasizing the cytokine interleukin-1 (IL-1). She has led clinical trials of IL-1 inhibitors and contributed to advancements in stroke treatment.

Key roles include Co-Chair of the Prime Minister’s Council for Science and Technology, President of the British Science Association, and membership in organizations like the Dementia Research Institute UK Board. Her awards include the Pfizer Research Prize (2003), FRS (2004), and DBE (2005).

Research interests span mechanisms of IL-1 release, inflammation’s impact on brain injury, and translational studies on stroke treatments. Her work bridges molecular, cellular, and clinical research, with collaborations at the University of Manchester and Salford Royal NHS Foundation Trust.

Notable projects include investigations into IL-1’s role in cerebral ischemia and clinical trials of Kineret. Her contributions to public science communication include Royal Institution Christmas Lectures and media appearances.